Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Arrakis37on Mar 28, 2018 9:44am
184 Views
Post# 27793426

While we're waiting

While we're waitingIn the case of a takeover, the price of the transaction will be determined by the valuation of the company realized by accountants, lawers and professionnals of the sector.  The share price and the market cap does not necessarily represent the reality of the valuation.  It represent the perception of the valuation.  So in others words the share price means NOTHING. 

I'm in the startup buisiness and I can tell it's really hard to tell how much worth a company when this company don't have started to sell his product.  But we already know the the big pharmas will do a lot to have this gem, so ask yourself : What is the fair price for Prometic ?  Under or over 900 millions ?  Which pharma will offer the best deal ?

So for now all the small investors including myself, analysts who study this company, bashers (paid or not), pumpers (paid or not), are in the perception mode.  The fair share price will came soon...

Bullboard Posts